Literature DB >> 933146

Clostridium difficile: isolation and characteristics.

S Hafiz, C L Oakley.   

Abstract

Clostridium difficile can be grown readily in Reinforced Clostridial Medium (RCM) containing 0-1-0-4% of o-, m- or p-cresol, or phenol. We recommend 0-2% of phenol or p-cresol in RCM for the isolation of this organism. The characteristic "cornfield" growth in RCM in 25-ml Universal containers is described. Glucose, fructose, galactose, mannose, raffinose, aesculin and mannitol are fermented with production of acid and gas; maltose, sucrose, glycogen, soluble starch and sorbitol are fermented with production of acid only. Lactose and rice starch are not fermented by any strain, and DL-methionine is not attacked. Nitrate is reduced to nitrite. Hydrogen sulphide and indole are not produced. Gelatin is attacked by all strains, but in some cases prolonged incubation is required. Hyaluronidase is produced, but not deoxyribonuclease. A lethal toxin appears to be produced. Strains possess shared and strain-specific antigens.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 933146     DOI: 10.1099/00222615-9-2-129

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  42 in total

Review 1.  Clostridial enteric diseases of domestic animals.

Authors:  J G Songer
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease.

Authors:  Krista M Newman; Kevin M Rank; Byron P Vaughn; Alexander Khoruts
Journal:  Gut Microbes       Date:  2017-01-19

3.  Evaluation of growth and sporulation of a non-toxigenic strain of Clostridioides difficile (Z31) and its shelf viability.

Authors:  Carlos Augusto Oliveira Júnior; Rodrigo Otávio Silveira Silva; Diogo Soares Gonçalves Cruz; Isadora Honorato Pires; Guilherme Guerra Alves; Francisco Carlos Faria Lobato
Journal:  Braz J Microbiol       Date:  2018-12-18       Impact factor: 2.476

4.  Clostridium difficile in neonates: serogrouping and epidemiology.

Authors:  M Delmée; G Verellen; V Avesani; G Francois
Journal:  Eur J Pediatr       Date:  1988-01       Impact factor: 3.183

Review 5.  Understanding the mechanisms of faecal microbiota transplantation.

Authors:  Alexander Khoruts; Michael J Sadowsky
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-22       Impact factor: 46.802

6.  Oral metronidazole in Clostridium difficile colitis.

Authors:  N L Pashby; R P Bolton; R J Sherriff
Journal:  Br Med J       Date:  1979-06-16

7.  Group B Streptococcus Evades Host Immunity by Degrading Hyaluronan.

Authors:  Stacey L Kolar; Pierre Kyme; Ching Wen Tseng; Antoine Soliman; Amber Kaplan; Jiurong Liang; Victor Nizet; Dianhua Jiang; Ramachandran Murali; Moshe Arditi; David M Underhill; George Y Liu
Journal:  Cell Host Microbe       Date:  2015-12-09       Impact factor: 21.023

8.  Improvement of Clostridium difficile isolation by heat-shock and typing of the isolated strains by SDS-PAGE.

Authors:  M Lahn; G Tyler; W Däubener; U Hadding
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

9.  Anaerobes in genitourinary infections in men.

Authors:  A N Masfari; G R Kinghorn; B I Duerden
Journal:  Br J Vener Dis       Date:  1983-08

10.  Haemophilus vaginalis (Corynebacterium vaginale, Gardnerella vaginalis) in a family planning clinic population.

Authors:  H M Bramley; R A Dixon; B M Jones
Journal:  Br J Vener Dis       Date:  1981-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.